FDA Approves EOVIST(R)
- This topic has 0 replies, 1 voice, and was last updated 16 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Thought it might be of interest to everyone.
MarionsFDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
Genetic Engineering News (press release) – New Rochelle,NY,USA
Lesions were characterized as one of the following choices: hepatocellular carcinoma, cholangiocarcinoma, metastasis, focal lymphoma, adenoma, focal nodular …
See all stories on this topic
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.